Business
Gold price today: How much 22K, 24K gold cost in Delhi, Mumbai & other cities – Check rates – The Times of India
Gold prices remained high on Monday as investors continued to seek safety amid rising geopolitical tensions and trade-related uncertainties.Gold and silver prices surged to fresh record levels as escalating geopolitical risks and shifting US monetary expectations boosted demand for safe-haven assets. Renewed unrest in Iran, fresh US tariff threats against several European countries over Greenland and broader global uncertainty supported buying in precious metals.On the MCX, gold February futures jumped nearly Rs 3,000, or over 2%, to hit a fresh all-time high of Rs 1,45,500 per 10 grams. Silver also outperformed, with futures rising sharply to record levels.In international markets, spot gold climbed 1.7% to a new high of $4,673 an ounce, while silver rose about 3% to around $94 per troy ounce. Overseas silver futures surged more than 6% to hit a record $94.35 per ounce.
Gold prices in Delhi today
Gold prices in Delhi rose on Monday. The price of 24-carat gold stood at Rs 14,584 per gram, up by Rs 191. The rate for 22-carat gold was Rs 13,370 per gram, higher by Rs 175, while 18-carat gold was priced at Rs 10,942 per gram, up by Rs 143.
Gold prices in Mumbai today
In Mumbai, 24-carat gold was priced at Rs 14,569 per gram, up by Rs 191. The price of 22-carat gold stood at Rs 13,355 per gram, up by Rs 175, while 18-carat gold was trading at Rs 10,927 per gram, up by Rs 143.
Gold prices in Chennai today
Gold prices in Chennai also moved higher. The price of 24-carat gold was Rs 14,673 per gram, up by Rs 186. The rate for 22-carat gold stood at Rs 13,450 per gram, up by Rs 170, while 18-carat gold was priced at Rs 11,230 per gram, up by Rs 140.
Gold prices in Ahmedabad today
In Ahmedabad, 24-carat gold was trading at Rs 14,574 per gram, up by Rs 191. The price of 22-carat gold rose to Rs 13,360 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,932 per gram, up by Rs 143.
Gold prices in Bhubaneswar today
Gold prices in Bhubaneswar rose on Monday, with 24-carat gold at Rs 14,569 per gram, up by Rs 191. The rate for 22-carat gold was Rs 13,355 per gram, up by Rs 175, while 18-carat gold stood at Rs 10,927 per gram, up by Rs 143.
Gold prices in Hyderabad today
In Hyderabad, gold prices remained firm. The price of 24-carat gold stood at Rs 14,569 per gram, up by Rs 191. The rate for 22-carat gold was Rs 13,355 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,927 per gram, up by Rs 143.
Gold prices in Kolkata today
Gold prices in Kolkata also moved higher. The price of 24-carat gold was Rs 14,569 per gram, up by Rs 191. The rate for 22-carat gold stood at Rs 13,355 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,927 per gram, up by Rs 143.
Gold prices in Jaipur today
In Jaipur, 24-carat gold was priced at Rs 14,584 per gram, up by Rs 191. The price of 22-carat gold stood at Rs 13,370 per gram, up by Rs 175, while 18-carat gold was trading at Rs 10,942 per gram, up by Rs 143.
Gold prices in Lucknow today
Gold prices in Lucknow rose on Monday, with 24-carat gold at Rs 14,584 per gram, up by Rs 191. The rate for 22-carat gold was Rs 13,370 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,942 per gram, up by Rs 143.
Gold prices in Bengaluru today
In Bengaluru, gold prices were higher, with 24-carat gold trading at Rs 14,569 per gram, up by Rs 191. The price of 22-carat gold stood at Rs 13,355 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,927 per gram, up by Rs 143.
Gold prices in Patna today
Gold prices in Patna also edged higher. The price of 24-carat gold stood at Rs 14,574 per gram, up by Rs 191. The rate for 22-carat gold was Rs 13,360 per gram, up by Rs 175, while 18-carat gold was priced at Rs 10,932 per gram, up by Rs 143.
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
Trump pays tribute to Lou Holtz after legendary football coach’s death
US Senate backs Trump’s Iran operations after House vote
Harry Kane calf injury imperils Bundesliga record chase
Attock Cement’s acquisition approved | The Express Tribune
What are Iran’s ballistic missile capabilities?
India Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week ago
Attock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days ago
India Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
-
Sports1 week agoSri Lanka’s Shanaka says constant criticism has affected players’ mental health
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’